Latest Kaiser Health News Stories
Buprenorphine is becoming an increasingly popular choice among doctors in California for treating opioid addiction. Use of methadone, while still more common, has not gained ground in recent years.
New data from the California agency that manages health benefits for 1.5 million public employees, retirees and their families shows that doctors are writing far fewer opioid prescriptions, reflecting a national trend of physicians cutting back on the addictive drugs.
For the seventh year in a row, Missouri will retain its lonely title as the only state without a statewide prescription drug monitoring program. Fears about privacy violations and gun control scuttled the bill yet again, leaving a pastiche of half-step measures in place to fill the void in the fight against prescription drug abuse.
More Republicans, at the statehouse level, are saying research and results support their endorsement of a once-controversial plan to limit disease among drug users.
A study looked at who gets Suboxone prescriptions and found that whites are almost 35 times more likely to get the addiction treatment than African Americans.
In the West and Midwest, 70% of local law enforcement says meth is the bigger threat. It’s also a more difficult addiction to treat.
After dozens of health care workers were charged with illegally prescribing opioids in Appalachia, local health agencies are trying to make sure chronic pain patients don’t fall through the cracks.
Executive editor Damon Darlin takes a spin as host of “The Friday Breeze,” whirling through a week of health care news so you don’t have to.
Once a tiny specialty that drew mostly psychiatrists, addiction medicine is expanding its accredited training to include primary care residents and “social justice warriors” who see it as a calling.
Overdose deaths involving fentanyl are soaring, says a new study from the CDC.
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.